Sources and privacy
Sources
- ER-100, first patient dosed in a Phase 1 trial for optic neuropathies, June 2026; first partial epigenetic reprogramming therapy cleared by the FDA for human trials: Longevity.Technology, Il Sole 24 Ore.
- Altos Labs, founded January 2022; first human trial planned for 2027: Lifespan.io, Fight Aging!.
- FlyWire whole-brain connectome of the adult fruit fly, nearly 140,000 neurons and more than 50 million synapses, Nature, October 2, 2024: NIH Research Matters.
Nothing on this site is medical advice, and nothing here promises anyone a longer life. We report what the evidence shows.
Your email
When you sign up, we store your email address, the date, which form you used, and your country as reported by our hosting provider. We use it for one thing: emailing you when a new story is published. We never sell or share it.
To protect the form from abuse we keep a one-way hash of your connection's IP address for rate limiting. It cannot be turned back into your address.
Every email includes an unsubscribe link. To have your address deleted entirely, write to will@yourforeverself.com and it will be removed.
Your Forever Self is operated by Verona Strategic LLC.